Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

Paulina Núñez F*, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro

*Autor correspondiente de este trabajo

Resultado de la investigación: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

Resumen

Inflammatory bowel diseases (IBD) are associated with various hepatobiliary disorders. They can occur at any moment in the course of the disease or associated with the treatment. The prevalence of liver dysfunction can reach up to 50% in different studies. Nonalcoholic fatty liver disease is considered the most common hepatobiliary complication in IBD, while primary sclerosing cholangitis is the most specific. Management of hepatic manifestations in IBD involves a multidisciplinary approach that includes a high index of suspicion and joint management with hepatologists. The medical confrontation with abnormal liver tests must include an exhaustive study to determine if these patterns can be related to IBD, associated diseases or to the therapies used.
Idioma originalInglés
Páginas (desde-hasta)319-337
Número de páginas19
PublicaciónWorld Journal of Hepatology
Volumen14
N.º2
DOI
EstadoPublicada - 27 feb. 2022

Nota bibliográfica

Publisher Copyright:
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Palabras clave

  • Extraintestinal manifestations
  • Hepatic steatosis
  • Inflammatory bowel disease
  • Liver toxicity
  • Sclerosing primary cholangitis

Huella

Profundice en los temas de investigación de 'Hepatobiliary manifestations in inflammatory bowel disease: A practical approach'. En conjunto forman una huella única.

Citar esto